αPD1-MSLN-CAR T cells

· Shanghai Cell Therapy Group Co.,Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for αPD1-MSLN-CAR T cells, covering 2023-07-14 to 2023-07-14. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Study of αPD1-MSLN-CAR T Cells in MSLN-positive Advanced Solid Tumors [Phase 1, Phase 2]